1. Incidence et prise en charge de l’anémie en transplantation rénale : une étude observationnelle française
- Author
-
Elisabeth Cassuto-Viguier, Chafik Hacen, Olivier Toupance, F. Martinez, Bernard Bourbigot, Gabriel Choukroun, Philippe Lang, Bertrand Dussol, Gilbert Deray, Hakim Mazouz, Yvon Lebranchu, Denis Glotz, and Nicole Lefrançois
- Subjects
Nephrology ,medicine.medical_specialty ,medicine.drug_class ,Anemia ,business.industry ,Renal function ,medicine.disease ,Erythropoiesis-stimulating agent ,Gastroenterology ,Surgery ,Transplantation ,Chronic allograft nephropathy ,Internal medicine ,medicine ,business ,Kidney transplantation ,Kidney disease - Abstract
The management of anemia after kidney transplantation remains poorly explored. The Management of Anemia in French Kidney Transplant Patients (MATRIX) study is an observational study conducted in 10 academic hospitals among kidney-transplant patients designed to evaluate the prevalence, associated factors and management of post-transplant anemia. Over two consecutive weeks, 418 recipients (males: 248; age: 50.8+/-12.7 years) were included, all were transplanted for more than six months. Mean serum creatinine (Scr) was 152+/-67 micromol/l and mean hemoglobin (Hb) was 12.4+/-1.8 g/dl (males: 12.8+/-1.9 g/dl; females 11.9+/-1.6 g/dl). Irrespective of the delay following transplantation, 23% of patients (n=95) were severely anemic (Hb < or = 11 g/dl). Eighteen percent of the patients received an antianemic treatment (10% oral iron, 7% erythropoiesis stimulating agents (ESA), 4% folic acid) and only 35% of the severely anemic patients were actually treated (n=33). A significantly-negative correlation was observed between eGFR and Hb levels (R= -0.347, p
- Published
- 2008
- Full Text
- View/download PDF